Recombinant Mouse DcTRAILR1/TNFRSF23 Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 8479-DT
Key Product Details
Product Specifications
Source
Mouse myeloma cell line, NS0-derived mouse DcTRAIL R1/TNFRSF23 protein
Met30-Ser156, with a C-terminal 6-His tag
Met30-Ser156, with a C-terminal 6-His tag
Purity
>95%, by SDS-PAGE with silver staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Met30
Predicted Molecular Mass
15 kDa
SDS-PAGE
23-30 kDa, reducing conditions
Activity
Measured by its binding ability in a functional ELISA.
When Recombinant Mouse DcTRAIL R1/TNFSF23 is immobilized at 0.1 μg/mL (100 μL/well), the concentration of Recombinant Mouse TRAIL/TNFSF10 (Catalog # 1121-TL) that produces 50% optimal binding response is approximately 2-12 ng/mL.
When Recombinant Mouse DcTRAIL R1/TNFSF23 is immobilized at 0.1 μg/mL (100 μL/well), the concentration of Recombinant Mouse TRAIL/TNFSF10 (Catalog # 1121-TL) that produces 50% optimal binding response is approximately 2-12 ng/mL.
Formulation, Preparation and Storage
8479-DT
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 500 μg/mL in PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: DcTRAILR1/TNFRSF23
References
- Truneh, A. et al. (2000) J. Biol. Chem. 275:23319.
- Schneider, P. et al. (2003) J. Biol. Chem. 278:5444.
- de la Casa Esperon, E. et al. (2012) Epigenetics 7:626.
- Ikeda, T. et al. (2010) J. Immunol. 185:5259.
Long Name
Decoy TRAIL Receptor 1
Alternate Names
DcTRAIL R1, SOB, TNFRH1, TNFRSF23
Entrez Gene IDs
79201 (Mouse)
Gene Symbol
TNFRSF23
UniProt
Additional DcTRAILR1/TNFRSF23 Products
Product Documents for Recombinant Mouse DcTRAILR1/TNFRSF23 Protein, CF
Product Specific Notices for Recombinant Mouse DcTRAILR1/TNFRSF23 Protein, CF
For research use only
Loading...
Loading...
Loading...